ENvue Medical Inc (FEED) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.55 is considered Undervalued compared with the five-year average of -0.00. The fair price of ENvue Medical Inc (FEED) is between 2.37 to 3.33 according to relative valuation method. Compared to the current price of 1.98 USD , ENvue Medical Inc By Undervalued By 16.62%.

Relative Value

Fair Zone

2.37-3.33

Current Price：1.98

16.62%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is ENvue Medical Inc (FEED) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

ENvue Medical Inc (FEED) has a current Price-to-Book (P/B) ratio of 0.06. Compared to its 3-year average P/B ratio of 0.09, the current P/B ratio is approximately -38.31% higher. Relative to its 5-year average P/B ratio of 0.09, the current P/B ratio is about -38.31% higher. ENvue Medical Inc (FEED) has a Forward Free Cash Flow (FCF) yield of approximately -273.10%. Compared to its 3-year average FCF yield of -180.40%, the current FCF yield is approximately 51.39% lower. Relative to its 5-year average FCF yield of -180.40%, the current FCF yield is about 51.39% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for FEED competitors is 0.41, providing a benchmark for relative valuation. ENvue Medical Inc Corp (FEED.O) exhibits a P/S ratio of 0.55, which is 33.97% above the industry average. Given its robust revenue growth of 92.02%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of FEED increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of FEED in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is FEED currently overvalued or undervalued?

What is ENvue Medical Inc (FEED) fair value?

FEED's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of ENvue Medical Inc (FEED) is between 2.37 to 3.33 according to relative valuation method.

How does FEED's valuation metrics compare to the industry average?

The average P/S ratio for FEED's competitors is 0.41, providing a benchmark for relative valuation. ENvue Medical Inc Corp (FEED) exhibits a P/S ratio of 0.55, which is 33.97% above the industry average. Given its robust revenue growth of 92.02%, this premium appears sustainable.

What is the current P/B ratio for ENvue Medical Inc (FEED) as of Mar 02 2026?

As of Mar 02 2026, ENvue Medical Inc (FEED) has a P/B ratio of 0.06. This indicates that the market values FEED at 0.06 times its book value.

What is the current FCF Yield for ENvue Medical Inc (FEED) as of Mar 02 2026?

As of Mar 02 2026, ENvue Medical Inc (FEED) has a FCF Yield of -273.10%. This means that for every dollar of ENvue Medical Inc's market capitalization, the company generates -273.10 cents in free cash flow.

What is the current Forward P/E ratio for ENvue Medical Inc (FEED) as of Mar 02 2026?

As of Mar 02 2026, ENvue Medical Inc (FEED) has a Forward P/E ratio of -0.00. This means the market is willing to pay $-0.00 for every dollar of ENvue Medical Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for ENvue Medical Inc (FEED) as of Mar 02 2026?

As of Mar 02 2026, ENvue Medical Inc (FEED) has a Forward P/S ratio of 0.55. This means the market is valuing FEED at $0.55 for every dollar of expected revenue over the next 12 months.

FEED Valuation